GlassScriptPhysician profile
Michael Marino
NPI 1134428790
$2,599.12
in general payments reported to CMS, 2019-2025
9 companies · $819 in 2025
The $819 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $252 · 2021: $70.63 · 2022: $81.61 · 2023: $25.99 · 2024: $925 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364 · Consulting Fee: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,363.85 |
| Consulting Fee | $406.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $814.87 | 2019-2025 | |
| Integra Lifesciences Corporation | $619.02 | 2021-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Medtronic, INC. | $253.70 | 2025 | Nim Vital, Biobutton |
| Stryker Corporation | $234.31 | 2020-2025 | Clarifix, Xpress Loprofile |
| Medtronic USA, INC. | $226.02 | 2019-2020 | |
| Intersect Ent, INC. | $220.52 | 2019-2020 | |
| Acclarent, INC | $108.88 | 2019-2022 | |
| Inspire Medical Systems, INC. | $97.22 | 2025 | Inspire |
| Optinose US, INC. | $24.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.